Drug
Orca Q
Orca Q: highest development phase Phase 1, developed by Orca Biosystems, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Orca Biosystems, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Orca-Q NCT06900192 | Phase 1 | Primary Progressive Multiple Sclerosis |
Latest
No recent events.
Follow Orca Q on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.